Alex Ovechkin’s ‘Ovi O’s’ Cereal Raises $44,008 for Children’s Cancer Research – NBC4 Washington

Ovechkin’s ‘Ovi O’s’ Breakfast Cereal Raises $44,008 for Cancer Research Originally Appeared on NBC Sports Washington

Aside from his legendary accolades, Alex Ovechkin’s humanitarian work has made a huge impact off the ice. On Thursday, the Washington Capitals attacker announced that his breakfast cereal, “Ovi O’s,” has raised $44,008 for childhood cancer research.

“It is an honor to hand over these ‘Ovi O’s’ funds to Children’s Cancer Foundation. Thank you, fans, for supporting a great cause,” Ovechkin said in a video the foundation posted on Twitter on Thursday.

According to the CCF Tweet, the money raised by Ovechkin and Giant Foods will help fund local childhood cancer research and programs for children suffering from cancer. Since the cereal was originally released, Giant Foods took clever steps to market the product, such as hiding autographed photos of the Caps forward in 50 random boxes of Ovi O’s in the area.

Ovechkin originally partnered with Giant Foods in September 2019 to bring the honey-nut breakfast treat to market, with a portion of all proceeds benefiting the Maryland-based nonprofit cancer research fund. He helped market the brand by visiting the DMV and surprising local schools, supermarkets and hospitals with boxes of Ovi O’s during its release week in 2019. Ovi O’s were so popular that they sold out shortly after release.

“Giant Food has been a sponsor of the Washington Capitals for more than three years and like all fans, we have enjoyed the spirit and energy Alex brings to the game and our local community,” Giant Food interim president Ira Kress said. get started. of the partnership. “Working together for such a fun and healthy product is a win-win for all of us. We are proud to offer a delicious breakfast cereal that will also help fund the important work of the Children’s Cancer Foundation.”

To learn more about the Children’s Cancer Foundation and how you can contribute, visit childrenscancerfoundation.org.

Comments are closed.